RESEARCH TRIANGLE PARK — RTI International has acquired New Jersey-based Medical Data Analytics (MDA), a provider of real-world evidence (RWE) generation to the pharmaceutical and biotechnology industry.
The terms of the deal were not disclosed.
RTI, with headquarters in RTP, said the acquisition expands existing services of its Health Solutions business unit “in design and conduct of observational research” with MDA’s capabilities in data collection and management, and physician and site recruitment.
“This acquisition fits directly with RTI’s corporate strategy of investing in our pharmaceutical services and commercial research business lines,” said E. Wayne Holden, PhD, president and CEO of RTI International, in a statement.
Founded in 2007, Medical Data Analytics started out as the health economics and outcomes research arm of our parent company, Market Certitude. It is known for its “scientific, rigorous, and efficient method of data collection” that uses screened and verified physicians as study investigators for data collection and validation.
“We’re pleased to have such a talented group of people joining our team. We look forward to ongoing collaboration with our new colleagues and are excited to have their expertise as we continue to strengthen our competitive position in the real-world evidence space,” said Chris Simmons, senior vice president of RTI Health Solutions, in a statement.
MDA will operate as separate business operation of RTI Health Solutions for a period of time to facilitate an “orderly transition,” RTI said in its release.
All employees of MDA are expected to remain with the company.
RTI researchers are tracking the spread of coronavirus using Twitter
